Clinical trial
Anti Cytokine Combination Therapy With Daclizumab and Infliximab for Treatment of Steroid Refractory Acute GVHD
NCT00574470 is registered in ClinicalTrials.gov with University of Iowa as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Anti Cytokine Combination Therapy With Daclizumab and Infliximab for Treatment of Steroid Refractory Acute GVHD
- Lead sponsor
- University of Iowa
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2006
- Completion date
- August 31, 2008
- Enrollment
- 3 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.